Short bio: Ksenia Takhistova, Co-Chair and General Counsel at CME, serves as Chief Legal Officer at LCM Biosensor Technologies. An experienced IP litigator and technology attorney, she advises clients on U.S. intellectual property law across diverse technologies. With expertise in patent litigation, including Hatch-Waxman cases, she represents clients in Federal District Courts, the International Trade Commission, and USPTO post-grant proceedings. Takhistova handles trade secret, antitrust, and licensing disputes, leveraging her mechanical and chemical engineering background to address complex technical fields like medical devices and life sciences. Takhistova fosters STEM talent and sustainable innovation.

Long bio: CME Co-Chair and General Counsel, Ms. Ksenia Takhistova is Chief Legal Officer at LCM Biosensor Technologies. She is an experienced IP litigator and technology attorney who counsels clients on US intellectual property law issues across a wide variety of modern and emerging technologies. She has substantial experience in all aspects of litigation, representing both plaintiffs and defendants in patent cases, including Hatch-Waxman litigations, before the Federal District Courts, at the International Trade Commission, in post-grant proceedings at the US Patent and Trademark Office, and in appeals from these proceedings. She has also handled other IP-related disputes, including trade secret, false advertising, and antitrust issues, in both Federal and State Courts. Ksenia represents clients in transactions, such as settlement negotiations and IP licensing discussions, and performs due diligence and opinion work, including freedom-to-operate, patentability, infringement and validity analyses. Drawing on her extensive educational and research background in the mechanical and chemical engineering arts, she is able to effectively handle disputes in technical fields, such as mechanical and medical devices, electrical and computer technology, life sciences, chemical, materials, and consumer products. Ksenia has served on the CME Board of Directors since April 2018.